Loading…
Palvella Therapeutics, Inc. is projected to rise to $194.63 by 2027, a +34% move from its current price of $144.76. PVLA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $139.08 | $144.86 | $150.88 | +0.07% |
| Jul 15 | $136.85 | $144.96 | $153.55 | +0.14% |
| Jul 16 | $135.18 | $145.06 | $155.66 | +0.21% |
| Jul 17 | $133.80 | $145.16 | $157.47 | +0.27% |
| Jul 18 | $132.62 | $145.26 | $159.10 | +0.34% |
| Jul 19 | $131.56 | $145.36 | $160.60 | +0.41% |
| Jul 20 | $130.60 | $145.45 | $162.00 | +0.48% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $130.60 | $145.45 | $162.00 | +0.48% |
| Week 2 | $125.50 | $146.15 | $170.20 | +0.96% |
| Week 3 | $121.86 | $146.85 | $176.98 | +1.45% |
| Week 4 | $118.96 | $147.56 | $183.03 | +1.93% |
| Week 5 | $116.53 | $148.27 | $188.65 | +2.42% |
| Week 6 | $114.43 | $148.98 | $193.96 | +2.91% |
| Week 7 | $112.57 | $149.69 | $199.06 | +3.41% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients with serious and rare genetic skin diseases. Its lead product candidate is QTORIN rapamycin, a novel, 3.9% anhydrous topical gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations.
The company also develops QTORIN rapamycin for the treatment of angiokeratomas and other mTOR-driven skin diseases; and QTORIN pitavastatin for the treatment of disseminated superficial actinic porokeratosis. The company is based in Wayne, Pennsylvania.
Palvella Therapeutics, Inc. trades with a current price of $148.21 and has a market capitalization of $2.13B. The stock is ranked 1988 by market capitalization. The price outlook shown in the forecast points to a bullish longer-term trajectory, with the average price at $148.21 in 2026 and rising to higher levels in subsequent years, including $289.38 on average by 2030 and $2,353.77 on average by 2050.
A major floor 43.9% below — a decisive break under it would weaken the trend.
The nearest floor, 29.4% below — buyers have tended to step in here.
The nearest ceiling, 7.0% above — a clean break opens room to run.
A major ceiling 28.9% above — clearing it would confirm fresh momentum.
Key PVLA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PVLA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $145.40 | Sell | $145.90 | Sell |
| MA 10 | $146.79 | Sell | $142.77 | Buy |
| MA 20 | $131.95 | Buy | $135.59 | Buy |
| MA 50 | $122.72 | Buy | $126.52 | Buy |
| MA 100 | $122.38 | Buy | $118.65 | Buy |
| MA 200 | $103.59 | Buy | $102.39 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.76 | Neutral |
| Stoch RSI (14) | 18.79 | Buy |
| CCI (20) | 55.95 | Neutral |
| Williams %R (14) | -27.88 | Info |
| MACD (12,26,9) | 1.19 | Buy |
| ROC (12) | 21.98 | Buy |
| Bollinger %B (20,2) | 0.69 | Neutral |
| Stochastic %K (14) | 72.12 | Neutral |
| TRIX (15) | 0.89 | Buy |
| Awesome (5,34) | 21.72 | Buy |
| Ultimate (7,14,28) | 51.32 | Neutral |
| Momentum (10) | 8.56 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 147.16 | Sell |
| ADX (14) | 20.66 | Buy |
| ATR (14) | 5.49 | Info |
The 30-day technical picture is bullish with RSI14 at 70. The stock is above the SMA50 of $118.93 and the SMA200 of $99.12, implying constructive momentum. Near-term support sits at $102.19 and resistance at $136.20, while the 30-day range spans from $115.02 to $190.98.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $76.43 | $144.76 | $199.58 | 0% | Neutral | |
| $147.91 | $194.63 | $274.73 | +34% | Bullish | |
| $156.17 | $214.73 | $319.13 | +48% | Bullish | |
| $170.28 | $242.95 | $375.75 | +68% | Bullish | |
| $195.99 | $289.05 | $462.11 | +100% | Bullish | |
| $228.89 | $348.03 | $572.61 | +140% | Bullish | |
| $323.68 | $506.50 | $854.90 | +250% | Bullish | |
| $361.14 | $580.74 | $1,003.03 | +301% | Bullish | |
| $333.76 | $550.95 | $971.82 | +281% | Bullish | |
| $385.13 | $652.06 | $1,172.75 | +350% | Bullish | |
| $644.79 | $1,229.00 | $2,395.78 | +749% | Bullish | |
| $1,042.27 | $2,316.15 | $5,064.19 | +15.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $76.43 | $144.76 | $173.93 | +0.00% |
| August 2026 | $124.72 | $149.10 | $184.37 | +3.00% |
| September 2026 | $127.51 | $154.08 | $193.67 | +3.34% |
| October 2026 | $122.86 | $149.82 | $190.91 | -2.76% |
| November 2026 | $119.63 | $147.03 | $189.49 | -1.87% |
| December 2026 | $123.79 | $153.26 | $199.58 | +4.24% |
Click any year to see its month-by-month PVLA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PVLA is projected to trade between $76.43 and $199.58, averaging $144.76 — a potential gain of 0% from today's $144.76. Price action looks broadly range-bound.
Palvella Therapeutics, Inc.'s 2027 outlook centres on $194.63, within a $147.91 to $274.73 range. That is up +34% on the projected 2026 average. That marks a +34% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, PVLA could reach as high as $319.13, with a base case around $214.73 and support toward $156.17 — roughly +48% from $144.76. Momentum favours further upside here.
Expect PVLA to range from $170.28 to $375.75 through 2029. The $242.95 average target implies a +68% move from current prices. That is up +13% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The PVLA price prediction for 2030 points to an average of $289.05 (low $195.99, high $462.11) — a potential gain of +100% on today's $144.76. Momentum favours further upside here.
In 2031, PVLA is projected to trade between $228.89 and $572.61, averaging $348.03 — a potential gain of +140% from today's $144.76. That is up +20% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Palvella Therapeutics, Inc.'s 2032 outlook centres on $506.50, within a $323.68 to $854.90 range. That is up +46% on the projected 2031 average. That marks a +250% change versus current levels. Momentum favours further upside here.
By 2033, PVLA could reach as high as $1,003.03, with a base case around $580.74 and support toward $361.14 — roughly +301% from $144.76. Buyers look set to stay in control over this stretch.
Expect PVLA to range from $333.76 to $971.82 through 2034. The $550.95 average target implies a +281% move from current prices. That is -5% versus the projected 2033 average. Momentum favours further upside here.
The PVLA price prediction for 2035 points to an average of $652.06 (low $385.13, high $1,172.75) — a potential gain of +350% on today's $144.76. Buyers look set to stay in control over this stretch.
In 2040, PVLA is projected to trade between $644.79 and $2,395.78, averaging $1,229.00 — a potential gain of +749% from today's $144.76. That is up +88% on the projected 2035 average. Momentum favours further upside here.
Palvella Therapeutics, Inc.'s 2050 outlook centres on $2,316.15, within a $1,042.27 to $5,064.19 range. That is up +88% on the projected 2040 average. That marks a +15.0x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in PVLA today (≈ 6.907986 PVLA) could be worth
$15,999.93
+$14,999.93 (+1500%) by 2050 · US Dollar
Based on the average projected PVLA price of $2,316.15 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PVLAwould be worth at today's price.
$1,000 invested in PVLA on Jul 10, 2025 (≈ 37.119524 PVLA) would be worth
$5,373.42
+$4,373.42 (+437.3%) today · 5.37× · US Dollar
Based on a PVLA entry price of $26.94 vs. today's $144.76.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $146.76 | $986.37 | -1.4% |
| 1 month ago | $102.19 | $1,416.58 | +41.7% |
| 3 months ago | $127.12 | $1,138.77 | +13.9% |
| 6 months ago | $100.49 | $1,440.54 | +44.1% |
| 1 year ago | $26.94 | $5,373.42 | +437.3% |
| All time (5.0y) ago | $278.4 | $519.97 | -48.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PVLA forecast.
Our base-case forecast reaches $290.00 around 2031.
Implied market cap at $290.00: $4.16B
The multi-year forecast shows bullish sentiment beyond 2026, with the 2026 average price of $148.21 and 0% ROI. The 2027 average is $193.31 with a 30.4% ROI, followed by 2028 at $221.12 (49.2%), 2029 at $245.54 (65.7%), and 2030 at $289.38 (95.3%). The trajectory continues with 2031 at $373.35 (151.9%), 2032 at $511.09 (244.8%), 2033 at $560.15 (277.9%), 2034 at $551.08 (271.8%), and 2035 at $650.80 (339.1%).
The forecast accelerates to $1,207.41 on average in 2040 (714.7% ROI) and $2,353.77 on average in 2050 (1488.1% ROI), with a bullish sentiment throughout those years. These are estimates and not guarantees, and actual results may differ.
Tap a question to reveal the answer.
Avg $289.38; min $199.03; max $456.19; ROI 95.3%; sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising averages; 2026 avg $148.21 and ROI 0%; long-term ROI reaches 714.7% in 2040 and 1488.1% in 2050.
2035 max $1,148.40 and 2040 max $2,302.31 indicate a path above $1,000 is possible.
Current price $148.21; Market cap $2.13B; Rank 1988.
Avg $1,207.41; min $655.95; max $2,302.31; ROI 714.7%; sentiment BULLISH.
Palvella Therapeutics, Inc. Community Discussion
0Share your Palvella Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.